Diamedica Therapeutics Financial Overview
Diamedica Therapeutics's market cap is currently $486.40M. The company's EPS TTM is $-0.17; its P/E ratio is ―; Diamedica Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
